Prostaglandin E2 suppresses hCAP18/LL-37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium tuberculosis infection
出版年份 2018 全文链接
标题
Prostaglandin E2 suppresses hCAP18/LL-37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium tuberculosis infection
作者
关键词
-
出版物
FASEB JOURNAL
Volume 32, Issue 5, Pages 2827-2840
出版商
FASEB
发表日期
2018-01-26
DOI
10.1096/fj.201701308
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosis
- (2017) Shashank Gupta et al. JOURNAL OF PATHOLOGY
- Antimicrobial peptides as novel anti-tuberculosis therapeutics
- (2016) João P. Silva et al. BIOTECHNOLOGY ADVANCES
- Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing ofMycobacterium tuberculosisin human macrophages
- (2015) Rokeya Sultana Rekha et al. Autophagy
- Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection
- (2015) Jonathan H Chen et al. NATURE MEDICINE
- Cathelicidin LL-37 induces time-resolved release of LTB4 and TXA2 by human macrophages and triggers eicosanoid generation in vivo
- (2014) Min Wan et al. FASEB JOURNAL
- Targeted Prostaglandin E2 Inhibition Enhances Antiviral Immunity through Induction of Type I Interferon and Apoptosis in Macrophages
- (2014) François Coulombe et al. IMMUNITY
- Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
- (2014) Katrin D. Mayer-Barber et al. NATURE
- Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2
- (2014) Alastair J O'Brien et al. NATURE MEDICINE
- Little Peptide, Big Effects: The Role of LL-37 in Inflammation and Autoimmune Disease
- (2013) J. M. Kahlenberg et al. JOURNAL OF IMMUNOLOGY
- Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis
- (2013) Cristina Vilaplana et al. JOURNAL OF INFECTIOUS DISEASES
- Tuberculosis
- (2013) Alimuddin Zumla et al. NEW ENGLAND JOURNAL OF MEDICINE
- E-type prostanoid receptor 4 (EP4) in disease and therapy
- (2013) Viktoria Konya et al. PHARMACOLOGY & THERAPEUTICS
- PGE2 suppression of innate immunity during mucosal bacterial infection
- (2013) Mallory Agard et al. Frontiers in Cellular and Infection Microbiology
- Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling
- (2012) Z. Zaslona et al. BLOOD
- Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
- (2012) David M. Tobin et al. CELL
- Prostaglandin E2 Suppresses Antifungal Immunity by Inhibiting Interferon Regulatory Factor 4 Function and Interleukin-17 Expression in T Cells
- (2012) Patricia A. Valdez et al. IMMUNITY
- An Important Role of Prostanoid Receptor EP2 in Host Resistance to Mycobacterium tuberculosis Infection in Mice
- (2012) V. Kaul et al. JOURNAL OF INFECTIOUS DISEASES
- The Cyclic AMP Pathway
- (2012) P. Sassone-Corsi Cold Spring Harbor Perspectives in Biology
- Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1
- (2011) Min Wan et al. FASEB JOURNAL
- International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
- (2011) D. F. Woodward et al. PHARMACOLOGICAL REVIEWS
- Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins
- (2011) C. Peres-Buzalaf et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans
- (2010) David M. Tobin et al. CELL
- The Vitamin D Receptor: New Paradigms for the Regulation of Gene Expression by 1,25-Dihydroxyvitamin D3
- (2010) J. Wesley Pike et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis
- (2010) Maziar Divangahi et al. NATURE IMMUNOLOGY
- Vitamin D3 Induces Autophagy in Human Monocytes/Macrophages via Cathelicidin
- (2009) Jae-Min Yuk et al. Cell Host & Microbe
- cAMP Stringently Regulates Human Cathelicidin Antimicrobial Peptide Expression in the Mucosal Epithelial Cells by Activating cAMP-response Element-binding Protein, AP-1, and Inducible cAMP Early Repressor
- (2009) Krishnendu Chakraborty et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human β-defensin 1 (HBD-1) expression in the intestinal epithelial cells
- (2008) Krishnendu Chakraborty et al. CELLULAR MICROBIOLOGY
- The role of the multifunctional peptide LL-37 in host defense
- (2008) Ylva Kai-Larsen Frontiers in Bioscience-Landmark
- Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2and LXA4in the induction of macrophage death
- (2008) Minjian Chen et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search